Have a feature idea you'd love to see implemented?
Let us know!
SANA Sana Biotechnology Inc
Price (delayed)
$2.35
Market cap
$524.68M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.4
Enterprise value
$489.94M
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and
Highlights
SANA's debt is down by 2.5% since the previous quarter
The EPS has declined by 22% since the previous quarter but it is up by 2.8% year-on-year
SANA's quick ratio is down by 14% from the previous quarter but it is up by 6% YoY
The net income is down by 25% since the previous quarter and by 11% year-on-year
The equity has contracted by 20% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of SANA
Market
Valuations
Earnings
Shares outstanding
223.27M
Market cap
$524.68M
Enterprise value
$489.94M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.79
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$305.81M
EBITDA
-$272.11M
Free cash flow
-$274.99M
Per share
Balance sheet
Liquidity
EPS
-$1.4
Free cash flow per share
-$1.17
Book value per share
$1.31
Revenue per share
$0
TBVPS
$1.53
Total assets
$559.39M
Total liabilities
$266.91M
Debt
$96.08M
Equity
$292.48M
Working capital
$163.15M
Debt to equity
0.33
Current ratio
4.47
Quick ratio
4.32
Net debt/EBITDA
0.13
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-50.4%
Return on equity
-94.5%
Return on invested capital
-99.7%
Return on capital employed
-59.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SANA stock price
How has the Sana Biotechnology stock price performed over time
Intraday
-7.11%
1 week
-9.27%
1 month
-40.2%
1 year
-41.4%
YTD
-42.4%
QTD
-43.51%
Financial performance
How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$312.48M
Net income
-$305.81M
Gross margin
N/A
Net margin
N/A
The net income is down by 25% since the previous quarter and by 11% year-on-year
The operating income has contracted by 24% from the previous quarter and by 10% YoY
Growth
What is Sana Biotechnology's growth rate over time
Valuation
What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
1.79
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 22% since the previous quarter but it is up by 2.8% year-on-year
SANA's P/B is 54% below its last 4 quarters average of 3.9
The equity has contracted by 20% YoY and by 14% from the previous quarter
Efficiency
How efficient is Sana Biotechnology business performance
The return on equity has declined by 41% year-on-year and by 32% since the previous quarter
Sana Biotechnology's ROA has decreased by 33% YoY and by 29% from the previous quarter
The company's return on invested capital fell by 31% YoY and by 26% QoQ
Dividends
What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SANA.
Financial health
How did Sana Biotechnology financials performed over time
The company's total assets is 110% higher than its total liabilities
SANA's quick ratio is down by 14% from the previous quarter but it is up by 6% YoY
The current ratio is down by 14% from the previous quarter but it is up by 7% YoY
SANA's debt is 67% smaller than its equity
The debt to equity rose by 27% year-on-year and by 14% since the previous quarter
The equity has contracted by 20% YoY and by 14% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.